NDC 62135-429

POSACONAZOLE

Posaconazole Delayed-release

POSACONAZOLE is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Chartwell Rx, Llc. The primary component is Posaconazole.

Product ID62135-429_f043ffa5-9564-4a98-e053-2995a90af810
NDC62135-429
Product TypeHuman Prescription Drug
Proprietary NamePOSACONAZOLE
Generic NamePosaconazole Delayed-release
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2019-08-28
Marketing CategoryANDA /
Application NumberANDA212411
Labeler NameChartwell RX, LLC
Substance NamePOSACONAZOLE
Active Ingredient Strength100 mg/1
Pharm ClassesAzole Antifungal [EPC], Azoles [CS]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 62135-429-60

60 TABLET in 1 BOTTLE (62135-429-60)
Marketing Start Date2022-12-12
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "POSACONAZOLE" or generic name "Posaconazole Delayed-release"

NDCBrand NameGeneric Name
0254-2045POSACONAZOLEposaconazole
0406-7711POSACONAZOLEposaconazole
0527-2133POSACONAZOLEPosaconazole
60687-523PosaconazolePosaconazole
70748-258POSACONAZOLEPOSACONAZOLE
0085-1328NOXAFILposaconazole
0085-2224NOXAFILposaconazole
0085-4324NOXAFILposaconazole
0085-4331NOXAFILposaconazole

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.